Partecipazione Italiana ed Opportunità
per il Tema Salute nel Programma NMBP
Donata Medaglini
Università degli Studi di Siena
Rappresentante Italiano nel Comitato di Programma H2020
“Nanotechnologies and Advanced Materials, Biotechnology, Advanced
Manufacturing and Processing”
(SC1) Health, demographic change and well-being:
Giornata Nazionale di Lancio dei Bandi NMBP 2016-17 in Horizon 2020
KETs: Key Enabling Technologies
•Six strategic technologies
•Driving competitiviness and growth opportunities
•Contribution to solving societal challenges
•Knowledge and capital intensity
•Cut across many sectors
The relevant topics of the work programme have been
developed identifying promising areas for cross-cutting KETs.
P
h
o
to
n
ic
s
N
an
o
tec
h
n
o
lo
gy
B
io
tec
h
n
o
lo
gy
A
d
va
n
ce
d
M
ater
ia
ls
M
ic
ro
a
n
d
N
an
o
ele
ctr
o
n
ic
s
Advanced
Manufactoring Systems
European KET Strategy:
•EC Communications
(2009) 512 & (2012) 341
H2020
Technology Transfer Success as a New product Product Launch Commercialization Success as a business Research DevelopmentL
o
s
s
e
s
/P
ro
fi
t
Time
Valley of Death
LEIT KETs: TRLs 3 – 7; centre at TRL 5
Budget/ Calls 2014-2015
NMP
49,2%
Total Budget 2014-2015 : 992,2 € million
Budget 2014: 485,52 € million
Budget 2015: 504 € million
Budget Calls NMBP 2014-2015
1 2 3 4 5 6 BIOTECH 7,9% Sustainable Process Industries 13,5% Energy Efficient Buildings 11,5% Contributions to other programme (ICT/WASTE) 1,8% Factories of the Future 16%NMP
49,2%
RISULTATI
NMBP CALLS 2014
9Calls
H2020-SPIRE-2014
H2020-FoF-2014
H2020-EeB-2014
H2020-NMP-2014-two-stage
H2020-NMP-PILOTS-2014
H2020-NMP-CSA-2014
H2020-NMP-GV-2014
H2020-LEIT-BIO-2014-1
H2020-SILC-II-2014
9 calls, 40 topics
Budget 485.52 M€
96 projects retained for
funding
No. Partecipanti italiani in proposte presentate No. Partecipanti italiani finanziati Tasso di successo partecipanti Italiani
813
122
15%
No. Proposte presentate a coordinamento italiano No. Coordinamenti italiani finanziati Tasso di successo coordinatori Italiani76
11
14,5%
Partecipazione
Coordinamento
Contributo finanziario per l’Italia
48.03 M €
(~10% del budget totale )
~
13% Progetti finanziati sono a Coordinamento ItalianoNo. proposte presentate No. Proposte finanziate Tasso medio di successo
603
96
16%
Risultati 2014 NMBP
(tasso medio di successo del programma NMBP: 8%)
11
Calls 2014 NMBP
2 1 ,4 5 1 7 ,0 3 9 7 ,0 8 4 ,3 6 10,9 9 6 4 ,1 8 1 1 ,2 6 4 9 ,4 2 9 ,8 7 4 8 ,0 3 1 ,4 6 3 9 ,5 5 5 ,4 7 1 6 ,3 8 4 9 ,2 8 1 ,2 3 0 ,7 0 2 ,0 5 0 ,2 2 0 ,5 4 1 ,1 5 0 ,0 8 0 ,8 4 0 ,0 0 5,91 0 ,4 8 7,9 6 0 ,0 1 0 ,0 0 4 ,6 0 3 ,4 1 1 ,7 3 0 ,0 0 6,78 1 ,4 0 0 ,6 1 €- €20 €40 €60 €80 €100 €120 AT BE DE DK EL ES FI FR IE IT LU NL PT SE UK BG CY CZ EE HR HU LT LV MT PL RO SI SK BR CH IL IS MXNO TR US
EU15 EU13 OTH
EC Funding (M€)
12
NMP- two stage -Results 2014 Calls
12
IT Participants Success Rate: ~ 29 % (selezionate/presentate)
IT Coordinators Success Rate: ~57 % (selezionate/presentate)
Funding to Italy:
~ 14.3% of EU funding
€- €5.000.000 €10.000.000 €15.000.000 €20.000.000 €25.000.000 AT BGCHCZDK EL FI HR IE IT LU MT NL PL RO SI TR US
EC funding by country
SME Instrument Phase 1
14
10 topics
Call budget 148.370.000 €
Eligible proposals: 467
Requested EC funding 3.028.423.780 €
Average size 6,484,847 €
90 above thresholds proposals (GO)
Requesting 625,410,847€ EC funding
Indicative success rate for 2
ndstage: 23.7%
15
H2020-NMP-2015-two-stage
Topics
NMP-11-2015 Nanomedicine therapy for cancer
NMP-12-2015 Biomaterials for treatment and prevention of Alzheimer’s disease
NMP-15-2015 Materials innovations for the optimisation of cooling in power plants
NMP-16-2015 Extended in-service life of advanced functional materials in energy technologies (capture, conversion, storage and/or transmission of energy)
NMP-19-2015 Materials for severe operating conditions, including added-value functionalities NMP-22-2015 Fibre-based materials for non-clothing applications
NMP-23-2015 Novel materials by design for substituting critical elements
NMP-24-2015 Low-energy solutions for drinking water production – pilot plants NMP-29-2015 Increasing the capacity to perform nano-safety assessment NMP-30-2015 Next generation tools for risk governance of Nanomaterials
16
H2020-NMP-2015-two-stage
Preliminary results
TOPICS
Eligible proposals
Go proposals
nb
Requested
EC funding
nb
Requested
EC funding
NMP-11-2015 63 468,871,420 12 (1 coord. IT) 97,900,000 NMP-12-2015 33 213,140,488 7 ( 1 coord IT) 49,371,800 NMP-15-2015 5 40,814,372 2 (1 coord IT) 16,000,000 NMP-16-2015 29 218,474,242 8 (1 coord IT) 65,350,370 NMP-19-2015 92 608,578,644 14 (3 coord IT) 102,624,976 NMP-22-2015 125 840,099,897 21 (2 coord IT) 138,594,667 NMP-23-2015 69 284,957,073 10 (5 coord IT) 45,511,105 NMP-24-2015 22 149,102,990 7 45,403,875 NMP-29-2015 23 160,009,978 7 48,732,986 NMP-30-2015 6 44,374,676 2 15,921,068 Total 467 3,028,423,780 90 (14 coord IT) 625,410,847NMBP Work Programme
2016-2017
NMBP Work Programme 2016-2017
Draft WP to PC 1st March 2015 2nd May 2015 Revised Draft WP PC Opinion 14 July2015 Adoption WP October 2017 Strategic DocumentCalls
2016-2017
Opening 15 October 2015 First deadline 8 December 2015Feedback from PC
PC Approval WP
Pre-Publication Draft WP September 2015
Pre-pubblication NMBP Work programme on
Horizon 2020 website
Budget/ Calls 2014-2015
NMP
49,2%
Total Budget 2016-2017 : 966,9 € million
Budget 2016: 447,2 € million
Budget 2017: 519,7€ million
Calls NMBP 2016-2017:Budget
1 2 3 4 5 6 BIOTECH Sustainable Process Industries 13,65% Energy Efficient Buildings 10.3% Factories of the Future 15%NMP
60% of the budget for NMBP Calls
39% of the Budget for PPP
CALLS FOR NANOTECHNOLOGIES
ADVANCED MATERIALS
ADVANCED MATERIALS AND NANOTECHNOLOGIES FOR HEALTHCARE
Year Topic Topic Title Instrument TRL Deadline
2016
NMBP 09-2016 Biomaterials for diagnosis and treatment of
demyelination disorders of the Central Nervous System RIA 3-5 1st Stage: 8/12/15
2nd Stage:24/5/16
NMBP 10-2016 Nanoformulation of biologicals RIA 3/4-5/6 NMBP 11-2016 ERA-NET on Nanomedicine ERA-NET
cofund 21/1/16
2017
NMBP 12-2017
Development of a reliable methodology for better risk management of engineered biomaterials in Advanced Therapy Medicinal Products and/or Medical Devices
RIA 4-6 12stnd Stage: 27/10/16 Stage: 4/5/17
NMBP 13-2017 Cross-cutting KETs for diagnostics at the point-of-care RIA 3/4-5/6 19/1/17 NMBP 14-2017 Regulatory Science Framework for assessment of risk
benefit ratio of Nanomedicines and Biomaterials IA 5-6
1st Stage: 27/10/16
2nd Stage: 4/5/17
NMBP 15-2017 Nanotechnologies for imaging cellular transplants and
regenerative processes in vivo RIA 3/4-5/6
1st Stage: 27/10/16
2nd Stage: 4/5/17
BIOTECHNOLOGY
Year Topic Topic Title Instrument TRL Deadline
2016
BIOTEC-01-2016 ERA-NET Cofund on Biotechnologies ERA-NET
Cofund 3-6 21/1/16 BIOTEC-02-2016 Bioconversion of non-agricultural waste into
biomolecules for industrial applications RIA 3-5
1st Stage: 8/12/15
2nd Stage: 24/5/16
BIOTEC-03-2016
Microbial chassis platforms with optimized metabolic pathways for industrial innovations through systems biology
RIA 3-5 BIOTEC-04-2016 KET Biotechnology foresight identifying gaps and
high-value opportunities for the EU industry CSA 21/1/16
2017
BIOTEC-05-2017 Microbial platforms for CO2-reuse processes in the
low-carbon economy RIA 3-5
1st Stage: 27/10/16
2nd Stage: 4/5/17
BIOTEC-06-2017
Optimisation of biocatalysis and downstream processing for the sustainable production of high value-added platform chemicals
IA 5-7 BIOTEC-07-2017 New Plant Breeding Techniques (NPBT) in molecular
farming: Multipurpose crops for industrial bioproducts RIA 3-5 BIOTEC-08-2017 Support for enhancing and demonstrating the impact of
MODELLING FOR THE DEVELOPMENT OF NANOTECHNOLOGIES AND
ADVANCED MATERIALS
Year Topic Topic Title Instrument TRL Deadline
2016
NMBP-23-2016
Advancing the integration of Materials Modelling in Business Processes to enhance effective industrial decision making and increase competitiveness
RIA 5 21ndst Stage: 8/12/15 Stage:24/5/16
NMBP-24-2016
Network to capitalise on strong European position in materials modelling and to allow industry to reap the benefits
CSA 21/1/16
2017 NMBP-25-2017
Next generation system integrating tangible and intangible materials model components to support innovation in industry
IA 6 1
st Stage: 27/10/16
SCIENCE-BASED RISK ASSESSMENT AND MANAGEMENT OF
NANOTECHNOLOGIES, ADVANCED MATERIALS AND BIOTECHNOLOGIES
Year Topic Topic Title Instrument TRL Deadline
2016
NMBP-26-2016 Analytical techniques and tools in support of
nanomaterial risk assessment RIA 5-6
1st Stage: 8/12/15
2nd Stage:24/5/16
NMBP-27-2016
Promoting safe innovation through global consolidation and networking of nanosafety centres and
strengthening the European industry through cooperation in nanosafety
CSA 21/1/16
2017
NMBP-28-2017
Framework and strategies for nanomaterial
characterisation, classification, grouping and read-across for risk analysis
RIA 5-7
1st Stage: 27/10/16
2nd Stage: 4/5/17
NMBP-29-2017 Advanced and realistic models and assays for
SME INSTRUMENT
Year Topic Topic Title Instrument TRL
2016 2017
SMEInst-02-2016-2017
Accelerating the uptake of nanotechnologies advanced materials or advanced manufacturing and processing technologies by SMEs SMEInst 2016 2017 SMEInst-03-2016-2017
Dedicated support to biotechnology SMEs closing the gap from
PILOTS
Year Topic Topic Title Instrument TRL Deadline
2016
PILOTS-01-2016 Pilot lines for manufacturing of materials with
customized thermal/electrical conductivity properties IA
4/6, target 7
1st Stage: 8/12/15
2nd Stage: 24/5/16
PILOTS-02-2016
Pilot Line Manufacturing of Nanostructured Antimicrobial Surfaces using Advanced Nanosurface Functionalization Technologies
IA 4/6,
target 7
2017
PILOTS-03-2017 Pilot Lines for Manufacturing of Nanotextured surfaces
with mechanically enhanced properties IA
4/6, target 7
1st Stage: 27/10/16
2nd Stage: 4/5/17
PILOTS-04-2017 Pilot Lines for 3D printed and/or injection moulded
polymeric or ceramic microfluidic MEMS IA
4/6, target 7 PILOTS-05-2017 Paper-based electronics RIA 3,
